FrancophonIA/ELRC3.0 huggingface dataset:
English: Voriconazole Accord is also used to prevent fungal infections in patients who have had haematopoietic (blood) stem-cell transplantation (a transplant of a type of stem cells that can develop into blood cells) and are at high risk of infection.
Danish: Voriconazole Accord anvendes desuden til forebyggelse af svampeinfektioner hos patienter, der har fået foretaget en hæmatopoietisk (blod)stamcelletransplantation (transplantation af en type stamceller, der kan udvikle sig til blodlegemer), og som har høj risiko for infektion.
English: The dose of Voriconazole Accord depends on the weight of the patient.
Danish: Doseringen af Voriconazole Accord afhænger af patientens vægt.
English: This means that Voriconazole Accord is similar to a ‘reference medicine' already authorised in the European Union (EU) called Vfend.
Danish: Det betyder, at Voriconazole Accord er identisk med et "referencelægemiddel", der allerede er godkendt i Den Europæiske Union (EU), og som hedder Vfend.
English: The Committee recommended that Voriconazole Accord be approved for use in the EU.
Danish: Udvalget anbefalede, at Voriconazole Accord godkendes til anvendelse i EU.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Voriconazole Accord has been shown to have comparable quality and to be bioequivalent to Vfend.
Danish: Agenturets Udvalg for Lægemidler til Mennesker (CHMP) konkluderede, at det i overensstemmelse med EU's krav er blevet påvist, at Voriconazole Accord er af sammenlignelig kvalitet og er bioækvivalent med Vfend.
English: A risk management plan has been developed to ensure that Voriconazole Accord is used as safely as possible.
Danish: Der er udarbejdet en risikostyringsplan for at sikre, at Voriconazole Accord anvendes så sikkert som muligt.
English: The loading dose is then followed by a maintenance dose that can be adjusted according to the patient's response.
Danish: Støddosen efterfølges af en vedligeholdelsesdosis, der kan tilpasses efter, hvordan lægemidlet virker hos patienten.
English: • candidaemia (another type of fungal infection due to Candida) in non-neutropenic patients
Danish: • candidæmi (en anden type svampeinfektion forårsaget af Candida) hos ikke-neutropene patienter
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Voriconazole Accord, including the appropriate precautions to be followed by healthcare professionals and patients.
Danish: På baggrund af denne er der anført sikkerhedsoplysninger i produktresuméet og indlægssedlen for Voriconazole Accord, herunder passende forholdsregler, som patienter og sundhedspersonale bør følge.
English: Voriconazole Accord is a ‘generic medicine'.
Danish: Voriconazole Accord er et "generisk lægemiddel".
English: When used for treating fungal infections, Voriconazole Accord is intended mainly for patients with worsening, possibly life-threatening, fungal infections.
Danish: Til behandling af svampeinfektioner er Voriconazole Accord hovedsagelig beregnet til patienter med fremadskridende og muligt livstruende svampeinfektioner.
English: Because Voriconazole Accord is a generic medicine, studies in patients have been limited to tests to determine that it is bioequivalent to the reference medicine, Vfend.
Danish: Da Voriconazole Accord er et generisk lægemiddel, har patientundersøgelserne været begrænset til tests for at påvise, at det er bioækvivalent med referencelægemidlet Vfend.
English: For more information about treatment with Voriconazole Accord, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Danish: Hvis du ønsker yderligere oplysninger om behandling med Voriconazole Accord, kan du læse indlægssedlen (også en del af denne EPAR) eller kontakte din læge eller dit apotek.
English: What measures are being taken to ensure the safe and effective use of Voriconazole Accord?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af Voriconazole Accord?
English: What are the benefits and risks of Voriconazole Accord?
Danish: Hvilke fordele og risici er der forbundet med Voriconazole Accord?
English: Voriconazole Accord is an antifungal medicine that contains the active substance voriconazole.
Danish: Voriconazole Accord er et lægemiddel mod svamp, som indeholder det aktive stof voriconazol.
English: Because Voriconazole Accord is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Danish: Da Voriconazole Accord er et generisk lægemiddel, som er bioækvivalent med referencelægemidlet, anses benefit/risk-forholdet for at være det samme som for referencelægemidlet.
English: Voriconazole Accord voriconazole
Danish: Voriconazole Accord voriconazol
English: Other information about Voriconazole Accord
Danish: Andre oplysninger om Voriconazole Accord
English: It is not intended to provide practical advice on how to use Voriconazole Accord.
Danish: Det er ikke en praktisk vejledning i, hvordan Voriconazole Accord bør anvendes.
English: What is Voriconazole Accord and what is it used for?
Danish: Hvad er Voriconazole Accord, og hvad anvendes det til?
English: For practical information about using Voriconazole Accord, patients should read the package leaflet or contact their doctor or pharmacist.
Danish: Hvis du ønsker praktisk vejledning om anvendelsen af Voriconazole Accord, kan du læse indlægssedlen eller kontakte din læge eller dit apotek.
English: The active substance in Voriconazole Accord, voriconazole, is an antifungal medicine that belongs to the ‘triazole' group.
Danish: Det aktive stof i Voriconazole Accord, voriconazol, er et svampemiddel i triazolgruppen.
English: The list of fungi against which Voriconazole Accord is active can be found in the summary of product characteristics (also part of the EPAR).
Danish: En liste over de svampearter, som Voriconazole Accord virker mod, fremgår af produktresuméet, der også er en del af denne EPAR.
English: Why is Voriconazole Accord approved?
Danish: Hvorfor blev Voriconazole Accord godkendt?
English: How is Voriconazole Accord used?
Danish: Hvordan anvendes Voriconazole Accord?
English: How has Voriconazole Accord been studied?
Danish: Hvordan blev Voriconazole Accord undersøgt?
English: How does Voriconazole Accord work?
Danish: Hvordan virker Voriconazole Accord?
English: For full information, see the package leaflet.
Danish: Yderligere oplysninger fremgår af indlægssedlen.
English: According to Article 71 of Directive 2001/82/EC of the European Parliament and of the Council as amended,
Danish: I henhold til artikel 71 i Europa-Parlamentets og Rådets direktiv 2001/82/EF, med senere ændringer,
English: These clinical signs have been reported very rarely from the field.
Danish: De kliniske symptomer er blevet rapporteret meget sjældent fra marken.
English: 2nd injection: after 3 weeks.
Danish: Anden injektion: efter 3 uger
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 15/01/2010
Danish: DATO FOR FØRSTE TILLADELSE/FORNYELSE AF TILLADELSEN Dato for første markedsføringstilladelse: 15/01/2010
English: Girona SPAIN
Danish: Girona SPANIEN
English: Date of last renewal: 07/11/2014
Danish: Dato for seneste fornyelse af markedsføringstilladelse: 07/11/2014
English: *(Cycling value (Ct) ≥ 36 by a validated RT-PCR method, indicating no presence of viral genome)
Danish: * (cyklusværdi (Ct) ≥ 36 bestemt med en valideret RT-PCR-metode, som ikke indikerede tilstedeværelse af viralt genom)
English: As the duration of immunity is not yet fully established, any revaccination scheme should be agreed by the Competent Authority or by the responsible veterinarian, taking into account the local epidemiological situation.
Danish: Da varigheden af immunitet endnu ikke er fuldstændig fastlagt, skal et revaccinationsprogram aftales med den ansvarlige myndighed eller den ansvarlige dyrlæge, der bør tage den lokale epidemiologiske situation med i betragtning.
English: Do not use this veterinary medicinal product after the expiry date which is stated on the carton and on the label after EXP.
Danish: Brug ikke dette veterinærlægemiddel efter den udløbsdato, der står på ydre emballage og etiketten efter EXP.
English: Aluminium hydroxide (Al3+)
Danish: Aluminiumhydroxid (Al3+)
English: Onset of immunity: 25 days after administration of the second dose.
Danish: Indtræden af immunitet: 25 dage efter administration af den anden dosis.
English: The duration of immunity is at least 1 year after the primary vaccination course.
Danish: Immunitetens varighed er mindst 1 år efter basisvaccinationsprogrammet.
English: Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu/
Danish: Yderligere information om dette lægemiddel er tilgængelig på Det Europæiske Lægemiddelagenturs hjemmeside http://www.ema.europa.eu/
English: Shelf-life of the veterinary medicinal product as packaged for sale: 1 year.
Danish: Opbevaringstid for veterinærlægemidlet i salgspakning: 1 år
English: D. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION The periodic safety update report (PSUR) cycle should be restarted for submission of 6 monthly reports (covering all authorised presentations of the product) for the next two years, followed by yearly reports for the subsequent two years and thereafter at 3 yearly intervals, unless otherwise required.
Danish: Den periodiske, opdaterede sikkerhedsindberetninger (PSUR) cyklus bør nulstilles før indsendelse af 6 månedlige rapporter (der dækker alle godkendte pakningsstørrelser af produktet) for de næste to år, efterfulgt af årlige rapporter for de efterfølgende to år og derefter på 3 års mellemrum, med mindre andet kræves.
English: b) the disease to which the product is intended to confer immunity is largely absent from the territory in question.
Danish: b) at den sygdom, som veterinærlægemidleter beregnet til at fremkalde immunitet mod, stort set ikke forekommer i det pågældende område.
English: Primary vaccination: Administer one dose of 2 ml according to the following vaccination scheme:
Danish: Basisvaccination: Administrer en dosis på 2 ml i henhold til følgende vaccinationsprogram:
English: Any person intending to manufacture, import, possess, sell, supply and use ZULVAC 8 Ovis must consult the relevant Member State's competent authority on the current vaccination policies prior to the manufacture, import, possession, sale, supply and/or use.
Danish: Enhver, som har til hensigt at fremstille, indføre, besidde, sælge, levere og/eller anvende ZULVAC 8 Ovis, skal rådføre sig med den relevante medlemsstats kompetente myndighed vedrørende gældende vaccinationspolitik forinden fremstilling, indførsel, besiddelse, salg, levering og/eller anvendelse finder sted..
English: Adjuvant:
Danish: Adjuvanser:
English: A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Danish: En beslutning om at anvende denne vaccine før eller efter et andet lægemiddel til dyr skal derfor tages fra gang til gang.
English: Inactivated bluetongue virus, serotype 8, strain BTV-8/BEL2006/02 RP* ≥ 1 *Relative Potency by a mice potency test compared to a reference vaccine that was shown efficacious in sheep.
Danish: Inaktiveret bluetonguevirus, serotype 8, stamme BTV-8/BEL2006/02 RP*≥ 1 *Relativ styrke bestemt ved en styrketest i mus, som blev sammenlignet med en referencevaccine, der blev påvist at være effektiv hos får.
English: WITHDRAWAL PERIOD Withdrawal period: zero days.
Danish: TILBAGEHOLDELSESTID Tilbageholdelsestid: 0 dage
English: Shelf-life after first opening the immediate packaging: use immediately.
Danish: Opbevaringstid efter første åbning af den indre emballage: anvendes straks
English: Special precautions for use in animals: Only use in healthy animals.
Danish: Special forholdsregler til brug hos dyr: Må kun anvendes til raske dyr.
English: DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED Detailed information on this product is available on the website of the European Medicines Agency (http://www.ema.europa.eu/).
Danish: DATO FOR SENESTE GODKENDELSE AF INDLÆGSSEDLEN Yderligere information om dette lægemiddel er tilgængelig på Det Europæiske Lægemiddelagenturs hjemmeside http://www.ema.europa.eu/
English: In this category of animals the vaccine should be used only according to the benefit/risk assessment by the responsible veterinarian and/or national Competent Authorities on the current vaccination policies against BTV.
Danish: Anvend derfor kun vaccinen til denne kategori af dyr i henhold til en benefit/risk-vurdering foretaget af den ansvarlige dyrlæge og/eller de nationale myndigheder, der er ansvarlige for den foreliggende vaccinationspolitik for bluetongue virus (BTV).
English: To stimulate active immunity against bluetongue virus, serotype 8 in sheep.
Danish: Til stimulation af aktiv immunitet mod bluetonguevirus, serotype 8 hos får.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION One dose of 2 ml of vaccine contains:
Danish: KVALITATIV OG KVANTITATIV SAMMENSÆTNING Hver dosis på 2 ml vaccine indeholder:
English: EXPIRY DATE EXP {month/year} Once broached use immediately.
Danish: EXP {måneder/år} Efter anbrud: anvendes straks.
English: Active immunisation of sheep from 1.5 months of age for the prevention* of viraemia caused by bluetongue virus, serotype 8.
Danish: Aktiv immunisering af får fra 1,5 måneders-alderen til forebyggelse* af viræmi, som er forårsaget af bluetonguevirus, serotype 8.
English: The import, possession, sale, supply and/or use of this veterinary medicinal product may be prohibited in Member States on the Whole or part of its territory.
Danish: Indførsel, besiddelse, salg, levering og/eller anvendelse af dette veterinærlægemiddel er eller kan være forbudt i en medlemsstat på dele af eller hele deres område.
English: Special precautions for use in animals Only use in healthy animals.
Danish: Særlige forsigtighedsregler vedrørende brug til dyr Må kun anvendes til raske dyr.
English: PACKAGE LEAFLET FOR: ZULVAC 8 Ovis suspension for injection for sheep
Danish: INDLÆGSSEDDEL TIL: ZULVAC 8 Ovis Suspension til injektion til får
English: The manufacture, import, possession, sale, supply and/or use of ZULVAC 8 Ovis may be prohibited in a Member State on the whole or part of its territory pursuant to national legislation.
Danish: Fremstilling, indførsel, besiddelse, salg, levering og/eller anvendelse af ZULVAC 8 Ovis er eller kan være forbudt i en medlemsstat på hele eller en del af dens område i henhold til nationale lovgivning.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE Carton box 1 x 100ml / Carton box 1 x 240 ml
Danish: OPLYSNINGER, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE Kartonæske med 1 x 100 ml / Kartonæske med 1 x 240 ml
English: Adjuvant(s):
Danish: Adjuvans (Adjuvanser):
English: METHOD AND ROUTE(S) OF ADMINISTRATION For subcutaneous use.
Danish: ANVENDELSESMÅDE OG INDGIVELSESVEJ(E) Subkutan anvendelse.
English: STATEMENT OF ACTIVE AND OTHER SUBSTANCES One dose of 2 ml contains:
Danish: ANGIVELSE AF AKTIVE STOFFER OG ANDRE STOFFER En dosis med 2 ml indeholder:
English: 6.5 Nature and composition of immediate packaging Type II glass bottle with butyl elastomer closure.
Danish: Type II glasflaske med butylelastomer-prop.
English: NAME OF THE VETERINARY MEDICINAL PRODUCT ZULVAC 8 Ovis suspension for injection for sheep
Danish: VETERINÆRLÆGEMIDLETS NAVN ZULVAC 8 Ovis injektionsvæske, suspension, til får
English: - very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment) - common (more than 1 but less than 10 animals in 100 animals) - uncommon (more than 1 but less than 10 animals in 1,000 animals) - rare (more than 1 but less than 10 animals in 10,000 animals) - very rare (less than 1 animal in 10,000 animals, including isolated reports)
Danish: − Ualmindelige (mere end 1, men mindre end 10 dyr i 1.000 dyr)
English: Incompatibilities Do not mix with any other veterinary medicinal product.
Danish: Uforligeligheder: Må ikke blandes med andre lægemidler til dyr.
English: PHARMACEUTICAL FORM Off-white or pink suspension for injection
Danish: LÆGEMIDDELFORM Elfenbenshvid eller lyserød injektionsvæske, suspension
English: PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE Vial label 100 ml / Vial label 240 ml
Danish: OPLYSNINGER, DER SKAL ANFØRES PÅ DEN INDRE EMBALLAGE Etiket 100 ml hætteglas / Etiket 240 ml hætteglas
English: STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S) One dose of 2 ml of vaccine contains:
Danish: ANGIVELSE AF DE(T) AKTIVE STOF(FER) OG ANDRE INDHOLDSSTOFFER Hver dosis på 2 ml vaccine indeholder:
English: The excipients (including adjuvants) listed in section 6.1 of the SPC are either allowed substances for which table 1 of the annex to Commission Regulation (EU) No 37/2010 indicates that no MRLs are required or are considered as not falling within the scope of Regulation (EC) No 470/2009 when used as in this veterinary medicinal product.
Danish: Hjælpestofferne (inclusive adjuvanter) som er anført i punkt 6.1 af SPC'et er enten tilladte hjælpestoffer, hvor tabel 1 i bilaget til Kommissionens forordning (EU) Nr. 37/2010 indikerer at
English: Potassium dihydrogen phosphate Disodium hydrogen phosphate dodecahydrate Sodium chloride
Danish: Kaliumdihydrogenphosphat Dinatriumhydrogenphosphatdodecahydrat Natriumchlorid
English: Once broached use immediately.
Danish: Efter anbrud: anvendes straks.
English: These reactions take the form in most cases of a general swelling of the injection site (persisting for not more than 9 days) or of palpable nodules (subcutaneous granuloma possibly persisting for more than 63 days).
Danish: Reaktionen er som oftest generel hævelse omkring injektionsstedet (varer højst 9 dage) eller mærkbare små knuder (subkutan granulom som kan vare i mere end 63 dage).
English: Name and address of the manufacturer(s) of the biological active substance(s) Zoetis Manufacturing & Research Spain, S.L.
Danish: Navn og adresse på fremstilleren (fremstillerne) af de(t) biologisk aktive stof(fer): Zoetis Manufacturing & Research Spain, S.L.
English: Pack of 1 bottle of 50 doses (100 ml).
Danish: Pakke med 1 flaske á 50 doser (100 ml) Pakke med 1 flaske á 120 doser (240 ml)
English: Pharmacotherapeutic group: Inactivated viral vaccines - bluetongue virus vaccine.
Danish: Farmakoterapeutisk gruppe: Inaktiverede virale vacciner - Vaccine mod bluetonguevirus, ATCvet-kode: QI04AA02
English: a) the administration of the product to animals will interfere with the implementation of national programme for the diagnosis, control or eradication of animal diseases, or will cause difficulties in certifying the absence of contamination in live animals or in foodstuffs or other products obtained from treated animals.
Danish: kan en medlemsstat i overensstemmelse med medlemsstatens nationale lovgivning forbyde fremstilling, indførsel, besiddelse salg, levering og/eller anvendelse af veterinærlægemidlet på hele eller en del af sit område, hvis det godtgøres: a) at behandling af dyr med veterinærlægemidletgriber forstyrrende ind i gennemførelsen af et nationalt program til diagnosticering, bekæmpelse eller udryddelse af sygdomme hos dyr eller gør det vanskeligt at bekræfte, at levende dyr eller levnedsmidler eller andre produkter hidrørende fra behandlede dyr ikke er kontamineret,
English: Name and address of the manufacturer(s) responsible for batch release Zoetis Manufacturing & Research Spain, S.L.
Danish: Navn og adresse på fremstilleren (fremstillerne) ansvarlig for batchfrigivelse: Zoetis Manufacturing & Research Spain, S.L.
English: Marketing authorisation holder Zoetis Belgium SA
Danish: INDEHAVEREN AF MARKEDSFØRINGSTILLADELSEN Zoetis Belgium SA
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER Zoetis Belgium SA
Danish: NAVN OG ADRESSE PÅ INDEHAVEREN AF MARKEDSFØRINGSTILLADELSEN Zoetis Belgium SA
English: Use in other domestic and wild ruminant species that are considered at risk of infection should be undertaken with care and it is advisable to test the vaccine on a small number of animals prior to mass vaccination.
Danish: Det tilrådes at afprøve vaccinen på et lille antal dyr før vaccination af hele populationen.
English: Can be used during pregnancy.
Danish: Veterinærlægemidlet kan anvendes under drægtighed.
English: CLINICAL PARTICULARS 4.1 Target species
Danish: 4.1 Dyrearter, som lægemidlet er beregnet til Får
English: A transient increase in rectal temperature, not exceeding 0.6 °C, may occur during the 24 hours following administration of a two-fold overdose.
Danish: Overdosering: Efter injektion af en dobbelt overdosis blev der rapporteret om en forbigående stigning rektaltemperaturen på højst 0,6 °C i løbet af de første 24 timer efter administration.
English: A transient increase in rectal temperature, not exceeding 0.6°C, may occur during the 24 hours following administration of a two-fold overdose.
Danish: I et laboratorium studie en forbigående stigning i rektaltemperaturen på højst 1,2°C forekom i løbet af de første 24 timer efter vaccination og en lokal reaktion på administrationsstedet efter vaccination.
English: ANNEX II A. MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE C. STATEMENT OF THE MRLs D. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION
Danish: FREMSTILLER(E) AF DE(T) BIOLOGISK AKTIVE STOF(FER) OG FREMSTILLER(E) ANSVARLIG FOR BATCHFRIGIVELSE
English: ADVERSE REACTIONS In one laboratory safety study, transient increase in rectal temperature during the 24 hours following vaccination not exceeding 1.2°C and local reaction at the injection site, in most cases in the form of a general swelling (persisting for not more than 7 days) or of palpable nodules (subcutaneous granuloma, possibly persisting for more than 48 days) were observed very commonly.
Danish: Reaktionen er som oftest generel hævelse omkring injektionsstedet (varer højst 7 dage) eller mærkbare små knuder (subkutan granulom som kan vare i mere end 48 dage).
English: When should I not have Truxima?
Danish: Hvornår må jeg ikke få Truxima?
English: • changes in laboratory tests carried out by your doctor.
Danish: • ændringer i laboratorieundersøgelser udført af din læge.
English: Date of first authorisation: 17 February 2017 Date of latest renewal:
Danish: Dato for første markedsføringstilladelse: 17. februar, 2017 Dato for seneste fornyelse:
English: Do not have Truxima if any of the above apply to you.
Danish: Du må ikke få Truxima, hvis ét eller flere af ovenstående punkter gælder for dig.
English: Do not have Truxima if you have an active infection or a serious problem with your immune system.
Danish: Du må ikke få Truxima, hvis du har en aktiv infektion eller alvorlige problemer med dit immunsystem.
English: Truxima may be used for the treatment of several different conditions in adults.
Danish: Truxima kan anvendes til behandling af flere forskellige tilstande hos voksne.
English: Some vaccines should not be given at the same time as Truxima or in the months after you receive Truxima.
Danish: Nogle vaccinationer bør ikke gives på samme tid som Truxima eller i månederne efter du har fået Truxima.
English: Truxima is indicated in adults for the following indications:
Danish: Truxima er indiceret hos voksne til følgende indikationer:
English: Truxima is a biosimilar medicinal product.
Danish: Truxima er et biosimilært lægemiddel.
English: Before you are given Truxima, you will be given other medicines (pre-medication) to prevent or reduce possible side effects.
Danish: Inden du får Truxima, vil du få anden medicin (præmedicin), der forebygger eller mindsker mulige bivirkninger.
English: Your doctor may decide to treat you longer with Truxima (up to 5 years), depending on how you respond to the medicine.
Danish: Din læge kan beslutte at behandle dig i længere tid med Truxima (op til 5 år), alt efter hvor godt du reagerer på medicinen.
English: You should also tell them about your Truxima treatment.
Danish: Du skal også fortælle dem om din Truxima-behandling.